MSC engineered to produce BDNF for the treatment of Huntington’s disease

• Post author:
• Post published:May 4, 2026
• Post category:

One in every ten thousand people in the USA has Huntington's disease, and it impacts many more. Multiple generations within a family can inherit the disease, resulting in escalating health…

Continue ReadingMSC engineered to produce BDNF for the treatment of Huntington’s disease

Treatment of non-traumatic osteonecrosis with endogenous Mesenchymal stem cells

• Post author:
• Post published:May 4, 2026
• Post category:

Although most individuals are aware that osteoporosis is disease of increased bone fragility that results from estrogen deficiency and aging, most are unaware of the high risk and cost of…

Continue ReadingTreatment of non-traumatic osteonecrosis with endogenous Mesenchymal stem cells

GENE-MODIFIED HEMATOPOIETIC STEM/PROGENITOR CELL BASED THERAPY FOR HIV DISEASE

• Post author:
• Post published:May 4, 2026
• Post category:

Continue ReadingGENE-MODIFIED HEMATOPOIETIC STEM/PROGENITOR CELL BASED THERAPY FOR HIV DISEASE

Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of MZ-1866, a gene therapy for Pitt Hopkins Syndrome

• Post author:
• Post published:May 2, 2026
• Post category:

Continue ReadingPhase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of MZ-1866, a gene therapy for Pitt Hopkins Syndrome

Phase I/II Clinical Trial for CMT4J

• Post author:
• Post published:May 2, 2026
• Post category:

Continue ReadingPhase I/II Clinical Trial for CMT4J

Phase 1B/2A study of the safety and tolerability of human neural stem cells for Huntington’s Disease (REGEN4HD)

• Post author:
• Post published:May 2, 2026
• Post category:

Continue ReadingPhase 1B/2A study of the safety and tolerability of human neural stem cells for Huntington’s Disease (REGEN4HD)

Inhibitory Interneuron Cell Therapy (NRTX-1001) for the Treatment of Drug-resistant Bilateral Temporal Lobe Epilepsy

• Post author:
• Post published:May 2, 2026
• Post category:

Continue ReadingInhibitory Interneuron Cell Therapy (NRTX-1001) for the Treatment of Drug-resistant Bilateral Temporal Lobe Epilepsy

The UCLA Delayed Immunological Tolerance after Kidney Transplantation Program

• Post author:
• Post published:May 2, 2026
• Post category:

Continue ReadingThe UCLA Delayed Immunological Tolerance after Kidney Transplantation Program

RPESC-RPE-4W Therapy for dry Age-related Macular Degeneration

• Post author:
• Post published:May 2, 2026
• Post category:

Continue ReadingRPESC-RPE-4W Therapy for dry Age-related Macular Degeneration

A phase 1/2 study to evaluate a bispecific CD19/CD20-directed CAR T cell, in refractory lupus nephritis and systemic lupus erythematosus

• Post author:
• Post published:May 2, 2026
• Post category:

Continue ReadingA phase 1/2 study to evaluate a bispecific CD19/CD20-directed CAR T cell, in refractory lupus nephritis and systemic lupus erythematosus